Oriola Oyj (HEL:ORIOLA)

Market Cap	207.47M
Revenue (ttm)	1.81B
Net Income (ttm)	-30.80M
Shares Out	185.25M
EPS (ttm)	-0.17
PE Ratio	n/a
Forward PE	18.27
Dividend	0.07 (6.29%)
Ex-Dividend Date	Apr 3, 2025

Volume	102,112
Average Volume	67,205
Open	1.100
Previous Close	1.108
Day's Range	1.100 - 1.120
52-Week Range	0.873 - 1.226
Beta	0.43
RSI	41.51
Earnings Date	Oct 30, 2025

About Oriola Oyj

Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally. The company also distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products; vaccines; and over-the-counter products. In addition, it provides pharmaceutical logistics; special licensed medicine importing, dose dispensing, and research pharmacy services; and commercial data, clinical trial, regulatory affairs and quality, medical and scientific affairs, market access and tend...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1907
• Employees: 934
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: ORIOLA

Financial Performance

In 2024, Oriola Oyj's revenue was 1.68 billion, an increase of 12.45% compared to the previous year's 1.50 billion. Losses were -20.10 million, -2.90% less than in 2023.